|
1）van Ijzendoorn MH, Bakermans-Kranenburg MJ. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology. 2012; 37: 438-43
|
|
|
|
2）Yamasue H, Yee JR, Hurlemann R, et al. Integrative Approaches Utilizing Oxytocin to Enhance Prosocial Behavior: From Animal and Human Social Behavior to Autistic Social Dysfunction. J Neurosci. 2012; 32: 14109-17
|
|
|
|
|
|
3）Yamasue H. Using endophenotypes to examine molecules related to candidate genes as novel therapeutics: The “endophenotype-associated surrogate endpoint (EASE)” concept. Neurosci Res. 2015; 99: 1-7
|
|
|
|
|
|
4）Yamasue H, Kuwabara H, Kawakubo Y, et al. Oxytocin, sexually dimorphic features of the social brain, and autism. Psychiatry Clin Neurosci. 2009; 63: 129-40
|
|
|
|
|
|
5）Watanabe T, Yahata N, Kawakubo Y, et al. Network structure underlying resolution of conflicting non-verbal and verbal social information. Soc Cogn Affect Neurosci. 2014; 9: 767-75
|
|
|
|
|
|
6）Watanabe T, Yahata N, Abe O, et al. Diminished Medial Prefrontal Activity Behind Autistic Social Judgments of Incongruent Information. PLoS One. 2012; 7: e39561
|
|
|
|
|
|
7）Watanabe T, Abe O, Kuwabara H, et al. Mitigation of Sociocommunicational Deficits of Autism Through Oxytocin-Induced Recovery of Medial Prefrontal Activity: A Randomized Trial. JAMA Psychiatry. 2014; 71: 166-75
|
|
|
|
|
|
8）Aoki Y, Watanabe T, Abe O, et al. Oxytocin?s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial. Mol Psychiatry. 2015; 20: 447-53
|
|
|
|
|
|
9）Aoki Y, Yahata N, Watanabe T, et al. Oxytocin improves behavioural and neural deficits in inferring others’ social emotions in autism. Brain. 2014; 137: 3073-86
|
|
|
|
|
|
10）Munesue T, Yokoyama S, Nakamura K, et al. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res. 2010; 67: 181-91
|
|
|
|
|
|
11）Kosaka H, Munesue T, Ishitobi M, et al. Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry. 2012; 12: 110
|
|
|
|
|
|
12）Tachibana M, Kagitani-Shimono K, Mohri I, et al. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2013; 23: 123-7
|
|
|
|
|
|
13）Anagnostou E, Soorya L, Chaplin W, et al. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012; 3: 16
|
|
|
|
|
|
14）Dadds MR, Macdonald E, Cauchi A, et al. Nasal Oxytocin for Social Deficits in Childhood Autism: A Randomized Controlled Trial. J Autism Dev Disord. 2014; 44: 521-31
|
|
|
|
|
|
15）Guastella AJ, Gray KM, Rinehart NJ, et al. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiatry. 2015; 56: 444-52
|
|
|
|
|
|
16）Watanabe T, Kuroda M, Kuwabara H, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015; 138: 3400-12
|
|
|
|
|
|
17）Aoki Y, Yamasue H. Reply: Does imitation act as an oxytocin nebulizer in autism spectrum disorder? Brain. 2015; 138: e361
|
|
|
|
|